Daraxonrasib doubles survival — a RAS‑targeting drug development breakthrough.
Sorensen recently reintroduced the bipartisan STOP GAMES Act, legislation aimed at preventing what he describes as "sham" ...
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout ...
FDA's draft guidance shows gene therapy developers how to use prior knowledge and platform data to accelerate regulatory ...
An expert interview explores the scientific necessity of patient experience data in amyotrophic lateral sclerosis drug ...
The FDA’s Center for Drug Evaluation and Research has accepted the first letter of intent for an in silico drug development tool into the agency’s Innovative Science and Technology Approaches for New ...
VANCOUVER, BC / ACCESS Newswire / June 9, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce the initiation of pro ...
Chai Discovery is working with major drugmakers to use its latest antibody AI model to find new therapies. Now it’s in talks ...
Plants are undeniably one of nature's most promising sources of new medicines, with monoterpenoid indole alkaloids (MIAs) ...
API scale-up success relies on choosing routes that balance efficiency, robustness, and manufacturability across development ...
Nurix (NRIX) stays a Strong Buy as bexobrutideg posts 83% ORR in r/r CLL and lands a $2.3B Roche deal—review the catalysts, ...
Options abound for hospitals looking to capitalize on these new data transfer technologies, but so do potential pitfalls. For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results